PION TCIⓇ 펌프를 사용한 AquafolTM 목표농도조절주입의 예측수행도 = Predictive performance of a target controlled infusion of AquafolTM by use of a PION TCIⓇ pump

다국어 초록 (Multilingual Abstract)

Background: The performance of a target controlled infusion (TCI) system needs to be confirmed in a clinical setting. AquafolTM, a microemulsion propofol, can be used for TCI with its pharmacokinetic parameters. The aim of this study is to evaluate the predictive performance of AquafolTM TCI by using a PION TCIⓇ pump incorporating the previously established pharmacokinetic parameters and ke0.
Methods: Thirty adult patients were enrolled in the study. General anesthesia was maintained with TCI of AquafolTM and remifentanil using a PION TCIⓇ pump. During the maintenance of anesthesia with a constant target effect-site concentration of propofol for at least for 20 minutes, blood was drawn and the propofol plasma concentration was measured. The predictive performance of AquafolTM TCI was evaluated by determining the median performance error (MDPE), median absolute performance error (MDAPE), divergence, and wobble from the intra-individual and pooled performance errors. The acceptability of the TCI system was determined based on the pooled predictive performance.
Results: A total of 153 propofol blood samples were analyzed. The estimates of pooled MDPE, MDAPE, divergence and wobble were 8.59% (1.61), 19.1% (1.12), −1.12%/h and 9.87% (1.01), respectively. The MDAPE indicating the accuracy of the TCI infusion system was within the clinically acceptable range (＜ 20–30%) and the bias (MDPE) was also acceptable (＜ 10–20%).
Conclusions: The performance of AquafolTM TCI using a PION TCIⓇ pump was acceptable for the clinical use.

참고문헌 (Reference)

1 김희수, "어린이에서 완전정맥마취시 목표조절주입법의 사용" 대한마취통증의학회 7 (7): 203-209, 2012

2 Schuttler J, "Total intravenous anaesthesia with propofol and alfentanil by computer-assisted infusion" 43 : 2-7, 1988

3 임경실, "The optimal concentrations of propofol at eye opening and orientation after propofol-remifentanil TCI in Koreans" 대한마취통증의학회 6 (6): 131-137, 2011

4 La Colla L, "Predictive performance of the ‘Minto' remifentanil pharmacokinetic parameter set in morbidly obese patients ensuing from a new method for calculating lean body mass" 49 : 131-139, 2010

5 Mertens MJ, "Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia" 90 : 132-141, 2003

6 Lee EH, "Physicochemical properties, pharmacokinetics, and pharmacodynamics of a reformulated microemulsion propofol in rats" 109 : 436-447, 2008

7 Coetzee JF, "Pharmacokinetic model selection for target controlled infusions of propofol. Assessment of three parameter sets" 82 : 1328-1345, 1995

8 Cortinez LI, "Performance of propofol target-controlled infusion models in the obese: pharmacokinetic and pharmacodynamic analysis" 119 : 302-310, 2014

9 Kim YH, "Nonlinear pharmacokinetics and clinical implications of blood-brain equilibration half-time of propofol" Ulsan University 2011

10 Struys M, "Miller's anesthesia" Elsevier Inc 919-957, 2015

11 Varvel JR, "Measuring the predictive performance of computer-controlled infusion pumps" 20 : 63-94, 1992

12 Minto CF, "Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development" 86 : 10-23, 1997

13 Jong-Yeop Kim, "Impact of priming the infusion system on the performance of target-controlled infusion of remifentanil" 대한마취통증의학회 64 (64): 407-413, 2013

14 Glen JB, "Evaluation of the predictive performance of four pharmacokinetic models for propofol" 102 : 626-632, 2009

15 Swinhoe CF, "Evaluation of the predictive performance of a ‘Diprifusor' TCI system" 53 (53): 61-67, 1998

16 Glen JB, "A comparison of the predictive performance of three pharmacokinetic models for propofol using measured values obtained during target-controlled infusion" 69 : 550-557, 2014